A reengineered hospital discharge program to decrease rehospitalization: a randomized trial
Brian W Jack, Veerappa K Chetty, David Anthony, Jeffrey L Greenwald, Gail M Sanchez, Anna E Johnson, Shaula R Forsythe, Julie K O'Donnell, Michael K Paasche-Orlow, Christopher Manasseh, Stephen Martin, Larry Culpepper, Brian W Jack, Veerappa K Chetty, David Anthony, Jeffrey L Greenwald, Gail M Sanchez, Anna E Johnson, Shaula R Forsythe, Julie K O'Donnell, Michael K Paasche-Orlow, Christopher Manasseh, Stephen Martin, Larry Culpepper
Abstract
Background: Emergency department visits and rehospitalization are common after hospital discharge.
Objective: To test the effects of an intervention designed to minimize hospital utilization after discharge.
Design: Randomized trial using block randomization of 6 and 8. Randomly arranged index cards were placed in opaque envelopes labeled consecutively with study numbers, and participants were assigned a study group by revealing the index card.
Setting: General medical service at an urban, academic, safety-net hospital.
Patients: 749 English-speaking hospitalized adults (mean age, 49.9 years).
Intervention: A nurse discharge advocate worked with patients during their hospital stay to arrange follow-up appointments, confirm medication reconciliation, and conduct patient education with an individualized instruction booklet that was sent to their primary care provider. A clinical pharmacist called patients 2 to 4 days after discharge to reinforce the discharge plan and review medications. Participants and providers were not blinded to treatment assignment.
Measurements: Primary outcomes were emergency department visits and hospitalizations within 30 days of discharge. Secondary outcomes were self-reported preparedness for discharge and frequency of primary care providers' follow-up within 30 days of discharge. Research staff doing follow-up were blinded to study group assignment.
Results: Participants in the intervention group (n = 370) had a lower rate of hospital utilization than those receiving usual care (n = 368) (0.314 vs. 0.451 visit per person per month; incidence rate ratio, 0.695 [95% CI, 0.515 to 0.937]; P = 0.009). The intervention was most effective among participants with hospital utilization in the 6 months before index admission (P = 0.014). Adverse events were not assessed; these data were collected but are still being analyzed.
Limitation: This was a single-center study in which not all potentially eligible patients could be enrolled, and outcome assessment sometimes relied on participant report.
Conclusion: A package of discharge services reduced hospital utilization within 30 days of discharge.
Funding: Agency for Healthcare Research and Quality and National Heart, Lung, and Blood Institute, National Institutes of Health.
Trial registration: ClinicalTrials.gov NCT00252057.
Figures


Source: PubMed
Tulevat kliiniset tutkimukset
-
NCT07680075Ei vielä rekrytointiaMotoriset taidot | Terve | Johtava toiminta
-
NCT07680088Ei vielä rekrytointia
-
NCT07680101Ei vielä rekrytointiaNivelreuma | Polven rappeuttava nivelsairaus
-
NCT07680114Ei vielä rekrytointia
-
NCT07680127Ei vielä rekrytointiaAivoturvotus | Säteilynekroosi
-
NCT07680140Ei vielä rekrytointiaKetamiini | fMRI | Masennus – vakava masennus | rTMS | Hoitoresistentti masennus (TRD)
-
NCT07680153Ei vielä rekrytointiafMRI | Kaksisuuntainen mielialahäiriö (BD) | rTMS | Kaksisuuntainen mielialahäiriö 1
-
NCT07680166Ei vielä rekrytointia
-
NCT07680179Ei vielä rekrytointiaItsemurha | Itsemurhien ehkäisy
-
NCT07680205RekrytointiFeokromosytooma | Feokromosytooma/paragangliooma | Feokromosytooma, metastaattinen | Pahanlaatuinen feokromosytooma | Feokromosytooma ja paraganglioma (PPGL)
-
NCT07680244RekrytointiEpiretinaalinen kalvo | Verkkokalvon sairaus | Kuivaan ikään liittyvä silmänpohjan rappeuma | Vitreoretinaalinen poikkeavuus | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal Pigment Epithelium (RPE) Atrophy
-
NCT07680257RekrytointiCLDN18.2 Positiiviset kiinteät kasvaimet